Jian Lin1, Xiaoli Liu2, Hailong Li1, Liling Yu1, Miaosen Shen3, Yongjin Lou3, Shuzhen Xie4, Jie Chen3, Rui Zhang5, Ti-Fei Yuan6. 1. Department of Rehabilitation Medicine, Zhejiang Hospital, Hangzhou, Zhejiang, China. 2. Ningbo Kangning Hospital, Ningbo, Zhejiang, China; Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China; School of Psychology, Nanjing Normal University, Nanjing, Jiangsu, China. 3. Fuchun Addiction Rehabilitation Center, 1 Heshangling Road, Fuyang, Hangzhou, Zhejiang, China. 4. Gudang Community Health Service Center, Hangzhou, Zhejiang, China. 5. Department of Rehabilitation Medicine, Zhejiang Hospital, Hangzhou, Zhejiang, China. Electronic address: Drzhangrui@163.com. 6. Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China; Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, China. Electronic address: ytf0707@126.com.
Abstract
BACKGROUND: Drug abstinence is accompanied by aversive experiences and lasting changes in mood status and worsening sleep quality. This study investigated the potential effects of chronic repetitive transcranial magnetic stimulation (rTMS) in substance dependent inpatients during abstinence. METHODS: This was a double-blinded study with 105 males inpatients dependent on heroin or methamphetamine (average abstinence time was six months). The inpatients were randomly divided into 10 Hz intervention (n = 40), sham stimulation (n = 40) and control (waiting list, no treatment) (n = 25) groups. Five sessions of rTMS stimulation were administrated for six consecutive weeks, reaching a total of 180,000 pulses. There was no intervention for control group. Patients were assessed using the Pittsburgh Sleep Quality Index (PSQI), Self-rating Anxiety Scale (SAS) and Self-rating Depression Scale (SDS) were assessed prior to and after six weeks of intervention. RESULTS: The results showed that six weeks of rTMS treatment significantly improved the sleep quality (p < 0.001), alleviated depression (p < 0.001) and anxiety state (p < 0.001) of substance dependent inpatients in early abstinence. Furthermore, the active TMS group showed significant differences between sham and control groups. CONCLUSION: These findings suggested that chronic rTMS treatment have positive effects for substance dependent inpatients during abstinence. Future studies are required to understand the underlying mechanism for improving different clinical symptoms.
RCT Entities:
BACKGROUND: Drug abstinence is accompanied by aversive experiences and lasting changes in mood status and worsening sleep quality. This study investigated the potential effects of chronic repetitive transcranial magnetic stimulation (rTMS) in substance dependent inpatients during abstinence. METHODS: This was a double-blinded study with 105 males inpatients dependent on heroin or methamphetamine (average abstinence time was six months). The inpatients were randomly divided into 10 Hz intervention (n = 40), sham stimulation (n = 40) and control (waiting list, no treatment) (n = 25) groups. Five sessions of rTMS stimulation were administrated for six consecutive weeks, reaching a total of 180,000 pulses. There was no intervention for control group. Patients were assessed using the Pittsburgh Sleep Quality Index (PSQI), Self-rating Anxiety Scale (SAS) and Self-rating Depression Scale (SDS) were assessed prior to and after six weeks of intervention. RESULTS: The results showed that six weeks of rTMS treatment significantly improved the sleep quality (p < 0.001), alleviated depression (p < 0.001) and anxiety state (p < 0.001) of substance dependent inpatients in early abstinence. Furthermore, the active TMS group showed significant differences between sham and control groups. CONCLUSION: These findings suggested that chronic rTMS treatment have positive effects for substance dependent inpatients during abstinence. Future studies are required to understand the underlying mechanism for improving different clinical symptoms.
Authors: Andrea R Collins; Joseph Cheung; Paul E Croarkin; Bhanu Prakash Kolla; Simon Kung Journal: J Clin Sleep Med Date: 2022-05-01 Impact factor: 4.324